It's never too early to kick off our 2025 NFL Power Rankings. After the Philadelphia Eagles beat the Kansas City Chiefs in ...

Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...

GREENFIELD — Sue Ann Wortman Cancer Center is doubling the size of its infusion center, where patients receive chemotherapy ...

A panel of 14 medical experts say that no babies were murdered in Lucy Letby's care. They have come together to publish what ...

Lucy Letby did not murder a single baby in her care, an international panel of experts has concluded.

EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC: Beerse, Belgium Tuesday, February ...

Baxalta spinoff was successful, Baxter's financial results fell substantially in 2022-23 on external pressures, such as inflation and weak medical utilization trends. With medical utilization rising, ...

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...

Aplagon, a clinical stage biopharmaceutical company developing a first-in-class therapeutic for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and ...

The U.S. Food and Drug Administration approved Eisai and Biogen’s application for IV maintenance dosing of lecanemab on January 27. Previously, the label called for biweekly IV dosing. The new ...

I critique Baxter International's capital allocation decisions, stating the stock is not suitable for popular investment strategies. See why I rate BAX a sell.